{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:35:09Z","timestamp":1787020509295,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"2023 Outstanding Young Teachers Program of Sanquan College of Xinxiang Medical University","award":["SQ2023YQJH08"],"award-info":[{"award-number":["SQ2023YQJH08"]}]},{"DOI":"10.13039\/501100005230","name":"The Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["CSTB2022NSCQ-MSX0764"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX0764"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Program for Youth Innovation in Future Medicine, Chongqing Medical University","award":["W0012"],"award-info":[{"award-number":["W0012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-04013-4","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:53:34Z","timestamp":1761047614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PMA exerts anti-leukemia effect in Ph+ ALL through activating PKC \u03b4 and its down-stream molecules"],"prefix":"10.1186","volume":"25","author":[{"given":"Xu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dachuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renren","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suotian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenglan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"2","key":"4013_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.blre.2016.09.001","volume":"31","author":"Y Ofran","year":"2017","unstructured":"Ofran Y, Izraeli S. BCR-ABL (Ph)-like acute leukemia-pathogenesis, diagnosis and therapeutic options. Blood Rev. 2017;31(2):11\u20136.","journal-title":"Blood Rev"},{"issue":"1","key":"4013_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13045-020-00912-3","volume":"13","author":"X Xiao","year":"2020","unstructured":"Xiao X, Liu P, Li D, Xia Z, Wang P, Zhang X, Liu M, Liao L, Jiao B, Ren R. Combination therapy of BCR-ABL-positive B cell acute lymphoblastic leukemia by tyrosine kinase inhibitor dasatinib and c-JUN N-terminal kinase Inhibition. J Hematol Oncol. 2020;13(1):80.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"4013_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.beha.2017.05.001","volume":"30","author":"NJ Short","year":"2017","unstructured":"Short NJ, Kantarjian H, Jabbour E, Ravandi F. Which tyrosine kinase inhibitor should we use to treat Philadelphia chromosome-positive acute lymphoblastic leukemia? Best Pract Res Clin Haematol. 2017;30(3):193\u2013200.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"4013_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1182\/blood-2006-11-052373","volume":"110","author":"H Pfeifer","year":"2007","unstructured":"Pfeifer H, Wassmann B, Pavlova A, Wunderle L, Oldenburg J, Binckebanck A, Lange T, Hochhaus A, Wystub S, Br\u00fcck P, et al. Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de Novo Philadelphia-positive acute lymphoblastic leukemia (Ph\u2009+\u2009ALL). Blood. 2007;110(2):727\u201334.","journal-title":"Blood"},{"issue":"2","key":"4013_CR5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/ajh.24926","volume":"93","author":"R El Fakih","year":"2018","unstructured":"El Fakih R, Jabbour E, Ravandi F, Hassanein M, Anjum F, Ahmed S, et al. Current paradigms in the management of Philadelphia chromosome positive acute lymphoblastic leukemia in adults. Am J Hematol. 2018;93(2):286\u201395.","journal-title":"Am J Hematol"},{"issue":"25","key":"4013_CR6","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1056\/NEJMra2113347","volume":"386","author":"R Fo\u00e0","year":"2022","unstructured":"Fo\u00e0 R, Chiaretti S. Philadelphia Chromosome-Positive acute lymphoblastic leukemia. N Engl J Med. 2022;386(25):2399\u2013411.","journal-title":"N Engl J Med"},{"issue":"12","key":"4013_CR7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nrd3871","volume":"11","author":"D Mochly-Rosen","year":"2012","unstructured":"Mochly-Rosen D, Das K, Grimes KV. Protein kinase C, an elusive therapeutic target? Nat Rev Drug Discov. 2012;11(12):937\u201357.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"4013_CR8","doi-asserted-by":"publisher","first-page":"L429","DOI":"10.1152\/ajplung.2000.279.3.L429","volume":"279","author":"EC Dempsey","year":"2000","unstructured":"Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA, Messing RO. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol. 2000;279(3):L429\u2013438.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4013_CR9","doi-asserted-by":"publisher","first-page":"155498","DOI":"10.1016\/j.cyto.2021.155498","volume":"142","author":"N Erin","year":"2021","unstructured":"Erin N, Tav\u015fan E, Akdeniz \u00d6, Isca VMS, Rijo P. Rebound increases in chemokines by CXCR2 antagonist in breast cancer can be prevented by PKC\u03b4 and PKC\u03b5 activators. Cytokine. 2021;142:155498.","journal-title":"Cytokine"},{"key":"4013_CR10","doi-asserted-by":"crossref","unstructured":"Bessa C, Loureiro JB, Barros M, Isca VMS, Sard\u00e3o VA, Oliveira PJ, et al. Counteracting colon cancer by inhibiting mitochondrial respiration and glycolysis with a selective PKC\u03b4 activator. Int J Mol Sci. 2023;24(6):5710 .","DOI":"10.3390\/ijms24065710"},{"issue":"2","key":"4013_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41419-017-0154-9","volume":"9","author":"C Bessa","year":"2018","unstructured":"Bessa C, Soares J, Raimundo L, Loureiro JB, Gomes C, Reis F, Soares ML, Santos D, Dureja C, Chaudhuri SR, et al. Discovery of a small-molecule protein kinase C\u03b4-selective activator with promising application in colon cancer therapy. Cell Death Dis. 2018;9(2):23.","journal-title":"Cell Death Dis"},{"issue":"21","key":"4013_CR12","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1016\/j.molcel.2021.08.039","volume":"81","author":"JF Linares","year":"2021","unstructured":"Linares JF, Zhang X, Martinez-Ordo\u00f1ez A, Duran A, Kinoshita H, Kasashima H, Nakanishi N, Nakanishi Y, Carelli R, Cappelli L, et al. PKC\u03bb\/\u03b9 Inhibition activates an ULK2-mediated interferon response to repress tumorigenesis. Mol Cell. 2021;81(21):4509\u2013e45264510.","journal-title":"Mol Cell"},{"issue":"3","key":"4013_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ccell.2019.01.018","volume":"35","author":"M Reina-Campos","year":"2019","unstructured":"Reina-Campos M, Linares JF, Duran A, Cordes T, L\u2019Hermitte A, Badur MG, Bhangoo MS, Thorson PK, Richards A, Rooslid T, et al. Increased Serine and One-Carbon pathway metabolism by PKC\u03bb\/\u03b9 deficiency promotes neuroendocrine prostate cancer. Cancer Cell. 2019;35(3):385\u2013e400389.","journal-title":"Cancer Cell"},{"issue":"1","key":"4013_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43690-5","volume":"14","author":"Y Muta","year":"2023","unstructured":"Muta Y, Linares JF, Martinez-Ordo\u00f1ez A, Duran A, Cid-Diaz T, Kinoshita H, et al. Enhanced SREBP2-driven cholesterol biosynthesis by PKC\u03bb\/\u03b9 deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesis. Nat Commun. 2023;14(1):8075.","journal-title":"Nat Commun"},{"key":"4013_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.semcancer.2017.04.017","volume":"48","author":"AC Newton","year":"2018","unstructured":"Newton AC. Protein kinase C as a tumor suppressor. Semin Cancer Biol. 2018;48:18\u201326.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"4013_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.cell.2015.01.001","volume":"160","author":"CE Antal","year":"2015","unstructured":"Antal CE, Hudson AM, Kang E, Zanca C, Wirth C, Stephenson NL, Trotter EW, Gallegos LL, Miller CJ, Furnari FB, et al. Cancer-associated protein kinase C mutations reveal kinase\u2019s role as tumor suppressor. Cell. 2015;160(3):489\u2013502.","journal-title":"Cell"},{"key":"4013_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156500","volume":"139","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, Gu W, Wu X, Tian W, Mu Z, Ye Y, et al. Allicin alleviates traumatic brain injury-induced neuroinflammation by enhancing PKC-\u03b4-mediated mitophagy. Phytomedicine. 2025;139:156500.","journal-title":"Phytomedicine"},{"key":"4013_CR18","doi-asserted-by":"publisher","first-page":"661505","DOI":"10.3389\/fnagi.2021.661505","volume":"13","author":"M Samidurai","year":"2021","unstructured":"Samidurai M, Palanisamy BN, Bargues-Carot A, Hepker M, Kondru N, Manne S, et al. PKC delta activation promotes Endoplasmic reticulum stress (ERS) and NLR family Pyrin Domain-Containing 3 (NLRP3) inflammasome activation subsequent to Asynuclein-induced microglial activation: involvement of Thioredoxin-Interacting protein (TXNIP)\/Thioredoxin (Trx) redoxisome pathway. Front Aging Neurosci. 2021;13:661505.","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"4013_CR19","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.immuni.2018.09.013","volume":"49","author":"Y Nakanishi","year":"2018","unstructured":"Nakanishi Y, Duran A, L\u2019Hermitte A, Shelton PM, Nakanishi N, Reina-Campos M, Huang J, Soldevila F, Baaten BJG, Tauriello DVF, et al. Simultaneous loss of both atypical protein kinase C genes in the intestinal epithelium drives serrated intestinal cancer by impairing immunosurveillance. Immunity. 2018;49(6):1132\u2013e11471137.","journal-title":"Immunity"},{"issue":"3","key":"4013_CR20","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cell.2016.09.030","volume":"167","author":"J Moscat","year":"2016","unstructured":"Moscat J, Karin M, Diaz-Meco MT. P62 in cancer: signaling adaptor beyond autophagy. Cell. 2016;167(3):606\u20139.","journal-title":"Cell"},{"issue":"16","key":"4013_CR21","doi-asserted-by":"publisher","first-page":"6418","DOI":"10.1073\/pnas.1221799110","volume":"110","author":"JY Kim","year":"2013","unstructured":"Kim JY, Valencia T, Abu-Baker S, Linares J, Lee SJ, Yajima T, et al. C-Myc phosphorylation by PKC\u03b6 represses prostate tumorigenesis. Proc Natl Acad Sci U S A. 2013;110(16):6418\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"4013_CR22","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.celrep.2018.03.118","volume":"23","author":"PM Shelton","year":"2018","unstructured":"Shelton PM, Duran A, Nakanishi Y, Reina-Campos M, Kasashima H, Llado V, et al. The secretion of miR-200s by a PKC\u03b6\/ADAR2 signaling axis promotes liver metastasis in colorectal cancer. Cell Rep. 2018;23(4):1178\u201391.","journal-title":"Cell Rep"},{"issue":"10","key":"4013_CR23","doi-asserted-by":"publisher","first-page":"880","DOI":"10.4161\/cbt.20840","volume":"13","author":"A Kawabata","year":"2012","unstructured":"Kawabata A, Matsuzuka T, Doi C, Seiler G, Reischman J, Pickel L, Ayuzawa R, Nguyen TA, Tamura M. C1B domain peptide of protein kinase C\u03b3 significantly suppresses growth of human colon cancer cells in vitro and in an in vivo mouse xenograft model through induction of cell cycle arrest and apoptosis. Cancer Biol Ther. 2012;13(10):880\u20139.","journal-title":"Cancer Biol Ther"},{"issue":"43","key":"4013_CR24","doi-asserted-by":"publisher","first-page":"39903","DOI":"10.1074\/jbc.M010281200","volume":"276","author":"X Zhao","year":"2001","unstructured":"Zhao X, Murata T, Ohno S, Day N, Song J, Nomura N, Nakahara T, Yokoyama KK. Protein kinase Calpha plays a critical role in mannosylerythritol lipid-induced differentiation of melanoma B16 cells. J Biol Chem. 2001;276(43):39903\u201310.","journal-title":"J Biol Chem"},{"issue":"3","key":"4013_CR25","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/(SICI)1098-2744(200003)27:3<166::AID-MC3>3.0.CO;2-Z","volume":"27","author":"ED Slosberg","year":"2000","unstructured":"Slosberg ED, Yao Y, Xing F, Ikui A, Jirousek MR, Weinstein IB. The protein kinase C beta-specific inhibitor LY379196 blocks TPA-induced monocytic differentiation of HL60 cells the protein kinase C beta-specific inhibitor LY379196 blocks TPA-induced monocytic differentiation of HL60 cells. Mol Carcinog. 2000;27(3):166\u201376.","journal-title":"Mol Carcinog"},{"issue":"40","key":"4013_CR26","doi-asserted-by":"publisher","first-page":"33926","DOI":"10.1074\/jbc.M505748200","volume":"280","author":"M Nakagawa","year":"2005","unstructured":"Nakagawa M, Oliva JL, Kothapalli D, Fournier A, Assoian RK, Kazanietz MG. Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cdelta-dependent induction of p21. J Biol Chem. 2005;280(40):33926\u201334.","journal-title":"J Biol Chem"},{"key":"4013_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.semcancer.2017.04.012","volume":"48","author":"N Isakov","year":"2018","unstructured":"Isakov N. Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression. Semin Cancer Biol. 2018;48:36\u201352.","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"4013_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/jnci\/82.6.501","volume":"82","author":"M Beckwith","year":"1990","unstructured":"Beckwith M, Longo DL, O\u2019Connell CD, Moratz CM, Urba WJ. Phorbol ester-induced, cell-cycle-specific, growth inhibition of human B-lymphoma cell lines. J Natl Cancer Inst. 1990;82(6):501\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"4013_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1006\/bcmd.2000.0348","volume":"27","author":"TJ Woodlock","year":"2001","unstructured":"Woodlock TJ, Bethlendy G, Segel GB. Prohibitin expression is increased in phorbol ester-treated chronic leukemic B-lymphocytes. Blood Cells Mol Dis. 2001;27(1):27\u201334.","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"4013_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008668","volume":"5","author":"M Daigneault","year":"2010","unstructured":"Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS ONE. 2010;5(1):e8668.","journal-title":"PLoS ONE"},{"issue":"2","key":"4013_CR31","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1006\/excr.1997.3847","volume":"238","author":"R Herrera","year":"1998","unstructured":"Herrera R, Hubbell S, Decker S, Petruzzelli L. A role for the MEK\/MAPK pathway in PMA-induced cell cycle arrest: modulation of megakaryocytic differentiation of K562 cells. Exp Cell Res. 1998;238(2):407\u201314.","journal-title":"Exp Cell Res"},{"issue":"6","key":"4013_CR32","first-page":"1445","volume":"52","author":"R Hass","year":"1992","unstructured":"Hass R, Gunji H, Datta R, Kharbanda S, Hartmann A, Weichselbaum R, Kufe D. Differentiation and retrodifferentiation of human myeloid leukemia cells is associated with reversible induction of cell cycle-regulatory genes. Cancer Res. 1992;52(6):1445\u201350.","journal-title":"Cancer Res"},{"key":"4013_CR33","doi-asserted-by":"crossref","unstructured":"Lee SH, Park NR, Kim JE. Bioinformatics of differentially expressed genes in phorbol 12-Myristate 13-Acetate-induced megakaryocytic differentiation of K562 cells by microarray analysis. Int J Mol Sci. 2022;23(8):4221.","DOI":"10.3390\/ijms23084221"},{"issue":"4","key":"4013_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-019-0264-y","volume":"20","author":"D Daassi","year":"2020","unstructured":"Daassi D, Mahoney KM, Freeman GJ. The importance of exosomal PDL1 in tumour immune evasion. Nat Rev Immunol. 2020;20(4):209\u201315.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"4013_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/13543784.2024.2319317","volume":"33","author":"D Kiem","year":"2024","unstructured":"Kiem D, Ocker M, Greil R, Neureiter D, Melchardt T. Enhancing anti-CD274 (PD-L1) targeting through combinatorial immunotherapy with bispecific antibodies and fusion proteins: from preclinical to phase II clinical trials. Expert Opin Investig Drugs. 2024;33(3):229\u201342.","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"4013_CR36","doi-asserted-by":"publisher","first-page":"304","DOI":"10.5603\/FHC.2012.0040","volume":"50","author":"A P\u0142oszy\u0144ska","year":"2012","unstructured":"P\u0142oszy\u0144ska A, Ruckemann-Dziurdzi\u0144ska K, J\u00f3\u017awik A, Mikosik A, Lisowska K, Balcerska A, Witkowski JM. Cytometric evaluation of transferrin receptor 1 (CD71) in childhood acute lymphoblastic leukemia. Folia Histochem Cytobiol. 2012;50(2):304\u201311.","journal-title":"Folia Histochem Cytobiol"},{"issue":"1","key":"4013_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13045-020-00865-7","volume":"13","author":"JM Dom\u00ednguez","year":"2020","unstructured":"Dom\u00ednguez JM, P\u00e9rez-Chac\u00f3n G, Guill\u00e9n MJ, Mu\u00f1oz-Alonso MJ, Somovilla-Crespo B, Cibri\u00e1n D, Acosta-Iborra B, Adrados M, Mu\u00f1oz-Calleja C, Cuevas C, et al. CD13 as a new tumor target for antibody-drug conjugates: validation with the conjugate MI130110. J Hematol Oncol. 2020;13(1):32.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"4013_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02918-3","volume":"20","author":"JN Nguyen","year":"2023","unstructured":"Nguyen JN, Mohan EC, Pandya G, Ali U, Tan C, Kofler JK, et al. CD13 facilitates immune cell migration and aggravates acute injury but promotes chronic post-stroke recovery. J Neuroinflammation. 2023;20(1):232.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"4013_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.it.2003.11.004","volume":"25","author":"JN Gass","year":"2004","unstructured":"Gass JN, Gunn KE, Sriburi R, Brewer JW. Stressed-out B cells? Plasma-cell differentiation and the unfolded protein response. Trends Immunol. 2004;25(1):17\u201324.","journal-title":"Trends Immunol"},{"issue":"10","key":"4013_CR40","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","volume":"21","author":"H Lavoie","year":"2020","unstructured":"Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol. 2020;21(10):607\u201332.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4013_CR41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1749-6632.1983.tb47836.x","volume":"407","author":"PM Blumberg","year":"1983","unstructured":"Blumberg PM, Delclos KB, Dunn JA, Jaken S, Leach KL, Yeh E. Phorbol ester receptors and the in vitro effects of tumor promoters. Ann N Y Acad Sci. 1983;407:303\u201315.","journal-title":"Ann N Y Acad Sci"},{"issue":"11\u201312","key":"4013_CR42","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/0145-2126(88)90014-8","volume":"12","author":"J Nishimura","year":"1988","unstructured":"Nishimura J, Takahira H, Shibata K, Muta K, Yamamoto M, Ideguchi H, Umemura T, Nawata H. Regulation of biosynthesis and phosphorylation of P210bcr\/abl protein during differentiation induction of K 562 cells. Leuk Res. 1988;12(11\u201312):875\u201385.","journal-title":"Leuk Res"},{"issue":"6","key":"4013_CR43","first-page":"585","volume":"48","author":"CH Lee","year":"1999","unstructured":"Lee CH, Yun HJ, Kang HS, Kim HD. ERK\/MAPK pathway is required for changes of Cyclin D1 and B1 during phorbol 12-myristate 13-acetate-induced differentiation of K562 cells. IUBMB Life. 1999;48(6):585\u201391.","journal-title":"IUBMB Life"},{"issue":"12","key":"4013_CR44","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1182\/blood.2024025429","volume":"144","author":"ES Wang","year":"2024","unstructured":"Wang ES. Curing APL in Latin America: more than just ATRA. Blood. 2024;144(12):1237\u20138.","journal-title":"Blood"},{"issue":"1","key":"4013_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13045-024-01559-0","volume":"17","author":"B Toledo","year":"2024","unstructured":"Toledo B, Zhu Chen L, Paniagua-Sancho M, Marchal JA, Per\u00e1n M, Giovannetti E. Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy. J Hematol Oncol. 2024;17(1):44.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"4013_CR46","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.str.2022.11.008","volume":"31","author":"JV Rodarte","year":"2023","unstructured":"Rodarte JV, Baehr C, Hicks D, Liban TL, Weidle C, Rupert PB, Jahan R, Wall A, McGuire AT, Strong RK, et al. Structures of drug-specific monoclonal antibodies bound to opioids and nicotine reveal a common mode of binding. Struct (London England: 1993). 2023;31(1):20\u2013e3225.","journal-title":"Struct (London England: 1993)"},{"key":"4013_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125688","volume":"678","author":"J Li","year":"2025","unstructured":"Li J, Yu J, Zhang B, Song J, Huang R, Li N, et al. Rational design of DXd derivatives for liposomal drug delivery: towards safer and more effective cancer treatments. Int J Pharm. 2025;678:125688.","journal-title":"Int J Pharm"},{"key":"4013_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.02.058","volume":"381","author":"L Liu","year":"2025","unstructured":"Liu L, Tu B, Sun Y, Liao L, Lu X, Liu E, et al. Nanobody-based drug delivery systems for cancer therapy. J Control Release. 2025;381:113562.","journal-title":"J Control Release"},{"key":"4013_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113991","volume":"385","author":"RM Pallares","year":"2025","unstructured":"Pallares RM, Barmin RA, Wang A, Kiessling F, Lammers T. Clinical cancer nanomedicines. J Control Release. 2025;385:113991.","journal-title":"J Control Release"},{"issue":"11","key":"4013_CR50","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/S0301-472X(99)00105-8","volume":"27","author":"A Foss\u00e5","year":"1999","unstructured":"Foss\u00e5 A, Brandhorst D, Myklebust JH, Seeber S, Nowrousian MR. Relation between s-phase fraction of myeloma cells and anemia in patients with multiple myeloma. Exp Hematol. 1999;27(11):1621\u20136.","journal-title":"Exp Hematol"},{"issue":"2","key":"4013_CR51","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrc.2016.138","volume":"17","author":"T Otto","year":"2017","unstructured":"Otto T, Sicinski P. Cell cycle proteins as promising targets in cancer therapy. Nat Rev Cancer. 2017;17(2):93\u2013115.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4013_CR52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang CV. MYC on the path to cancer. Cell. 2012;149(1):22\u201335.","journal-title":"Cell"},{"key":"4013_CR53","doi-asserted-by":"publisher","first-page":"748852","DOI":"10.3389\/fphar.2021.748852","volume":"12","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Gao X, Yuan M, Yang B, He Q, Cao J. Targeting Myc interacting proteins as a winding path in cancer therapy. Front Pharmacol. 2021;12:748852.","journal-title":"Front Pharmacol"},{"key":"4013_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2023.102288","volume":"86","author":"MJ Jones","year":"2024","unstructured":"Jones MJ, Jones MC. Cell cycle control by cell-matrix interactions. Curr Opin Cell Biol. 2024;86:102288.","journal-title":"Curr Opin Cell Biol"},{"issue":"16","key":"4013_CR55","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1038\/sj.onc.1208326","volume":"24","author":"Y Guo","year":"2005","unstructured":"Guo Y, Yang K, Harwalkar J, Nye JM, Mason DR, Garrett MD, et al. Phosphorylation of cyclin D1 at Thr 286 during S phase leads to its proteasomal degradation and allows efficient DNA synthesis. Oncogene. 2005;24(16):2599\u2013612.","journal-title":"Oncogene"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04013-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-04013-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04013-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:03:52Z","timestamp":1761091432000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-04013-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4013"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-04013-4","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research conformed to the standard stipulated by Declaration of Helsinki and was performed with the approval of the ethical committee of Chongqing Medical University (Approval No. 2021039). And informed consent was obtained from each subject.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"365"}}